Assessment of Alternative Energy/Environment Futures for Austria, 1977-2015: An Executive Summary

This report was prepared to complement a presentation made October 25, 1977 at IIASA. The presentation, titled "An Executive Briefing Session", was designed to present the final results of a thirteen-month study of the Austrian Energy/Environment System to leaders in Austrian government, industry, and science. This written documentation of the results (of which a German translation is also available) presents in a brief form the final conclusions of this study. The study results provide a comprehensive spatial and sectoral description of Austrian energy consumption, and examine alternative energy and environmental policy strategies. This report, however, is only a summary and a more complete description will appear in Research Report form in 1978

Assessment of Alternative Energy/Environment Futures for Austria: 1977-2015

The Austrian Regional Energy/Environment Study is the fourth in a series of IIASA studies on regional energy and environmental systems. The regions studied previously were the German Democratic Republic, the Rhone-Alpes Region in France and the state of Wisconsin in the U.S.A. The Austrian case study, regional in scope, complements the work of the IIASA Energy Systems Program which focuses primarily on global aspects of energy. This report presents the major results of the l5-month, Austrian case study, which examines alternative energy futures and strategies for Austria and some of their environmental implications. A secondary objective is the development of appropriate concepts and methods for energy/environment management and policy design in Austria

Assessment of Alternative Energy/Environment Futures for Austria 1977-2015: Final Summary Report

This study had two primary objectives: (1) To examine alternative energy futures and strategies for Austria and to consider some of their environmental implications. (2) To investigate and apply appropriate concepts and . methodologies for energy/environment management and policy design in Austria. The establishment of these objectives was based upon the conviction that in Austria, as in most regions and nations of the world, there is an urgent need for the development and application of methods for studying regional energy systems and for testing the impact of alternative policies. In view of the major role which energy plays in the determination of environmental quality, this study was designed to aid in the integration of energy and environmental management from a systems perspective. "Regional," in the context of our previous studies, is not strictly defined as subnational or as a specific class of geographic units; rather, it refers to a region, appropriately bounded so that it is possible to speak of energy and environmental systems from a physical, socioeconomic, or administrative perspective, or from all three. At the beginning of this study, we intended to limit its scope to a selected few Austrian Lander (states); we quickly realized that Austria's size and vigorous interregional links precluded anything less than a national study

The Wisconsin-IIASA Set of Energy/Environment (WISE) Models for Regional Planning and Management: An Overview

This report presents an overview of the analytical framework and quantitative methods used in the IIASA case studies on Regional Energy/Environment Management and Planning. Its purpose is to summarize the structure of the models, to provide a complete listing of the sources of more detailed model and data descriptions, and to indicate how the models are integrated to provide a foundation for regional energy/environment policy maker analysis. The audience for the report includes managers, planners, technical advisors, and modelers. The set of models used in the research project encompasses socioeconomic links to the energy system; energy demand in the residential, industrial, commercial/service, agricultural and transportation sectors; the energy supply sector, environmental impacts associated with the energy system; and policy makers' preferences. The report gives a brief description of the purpose and general structure of each model, data requirements, examples of input and output, and model limitations. As a whole, the models integrate information about energy flows in a region to simulate the energy system and its relationship to other regional variables, e.g., demographic and economic trends and the environment

Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients

Abstract: Autoinflammation is the standard mechanism seen in systemic autoinflammatory disease (SAID) patients. This study aimed to investigate the effect of a candidate miRNA, miR-30e-3p, which was identified in our previous study, on the autoinflammation phenotype seen in SAID patients and to analyze its expression in a larger group of European SAID patients. We examined the potential anti-inflammatory effect of miR-30e-3p, which we had defined as one of the differentially expressed miRNAs in microarray analysis involved in inflammation-related pathways. This study validated our previous microarray results of miR-30e-3p in a cohort involving European SAID patients. We performed cell culture transfection assays for miR-30e-3p. Then, in transfected cells, we analyzed expression levels of pro-inflammatory genes; IL-1β, TNF-α, TGF-β, and MEFV. We also performed functional experiments, caspase-1 activation by fluorometric assay kit, apoptosis assay by flow cytometry, and cell migration assays by wound healing and filter system to understand the possible effect of miR-30e-3p on inflammation. Following these functional assays, 3'UTR luciferase activity assay and western blotting were carried out to identify the target gene of the aforementioned miRNA. MiR-30e-3p was decreased in severe European SAID patients like the Turkish patients. The functional assays associated with inflammation suggested that miR-30e-3p has an anti-inflammatory effect. 3'UTR luciferase activity assay demonstrated that miR-30e-3p directly binds to interleukin-1-beta (IL-1β), one of the critical molecules of inflammatory pathways, and reduces both RNA and protein levels of IL-1β. miR-30e-3p, which has been associated with IL-1β, a principal component of inflammation, might be of potential diagnostic and therapeutic value for SAIDs. Key Messages: miR-30e-3p, which targets IL-1β, could have a role in the pathogenesis of SAID patients.miR-30e-3p has a role in regulating inflammatory pathways like migration, caspase-1 activation.miR-30e-3p has the potential to be used for future diagnostic and therapeutic approaches.</p

Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases

Calgranulins are a family of powerful chemoattractants, which have been implicated as biomarkers in inflammatory diseases. To determine how different respiratory diseases affect the expression of calgranulins, we measured the expression of S100A8/A9 and S100A12 in bronchoalveolar lavage fluid (BALF) of ARDS patients and healthy volunteers by ELISA. Analysis of calgranulin expression revealed a high level of S100A12 in the lavages of patients suffering from ARDS compared to controls (p< 0.001). Based on the hypothesis that the increased expression of S100A12 relative to the S100A8/A9 heterodimer was a characteristic of respiratory diseases with neutrophilic inflammation, we measured calgranulin expression in BALF of cystic fibrosis (CF) patients. Despite similarly elevated levels of S100A8/A9, S100A12 was significantly higher in ARDS compared to CF BALF (p<0.001). The differential expression of calgranulins was unique for inflammatory markers, as an array of cytokines did not differ between CF and ARDS patients

Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.

BACKGROUND: Calprotectin is a calcium-binding cytoplasmic protein found in neutrophils and increasingly used as a marker of bowel inflammation. Fecal occult blood (FOB) is also a dependable indicator of bowel morbidity. The objective of our study was to determine the applicability of these tests as surrogate markers of Schistosoma mansoni intestinal morbidity before and after treatment with praziquantel (PZQ). METHODS: 216 children (ages 3-9 years old) from Buliisa District in Lake Albert, Uganda were examined and treated with PZQ at baseline in October 2012 with 211 of them re-examined 24 days later for S. mansoni and other soil transmitted helminths (STH). POC calprotectin and FOB assays were performed at both time points on a subset of children. Associations between the test results and infection were analysed by logistic regression. RESULTS: Fecal calprotectin concentrations of 150-300 µg/g were associated with S. mansoni egg patent infection both at baseline and follow up (OR: 12.5 P = 0.05; OR: 6.8 P = 0.02). FOB had a very strong association with baseline anemia (OR: 9.2 P = 0.03) and medium and high egg intensity schistosomiasis at follow up (OR: 6.6 P = 0.03; OR: 51.3 P = 0.003). Both tests were strongly associated with heavy intensity S. mansoni infections. There was a significant decrease in FOB and calprotectin test positivity after PZQ treatment in those children who had egg patent schistosomiasis at baseline. CONCLUSIONS: Both FOB and calprotectin rapid assays were found to correlate positively and strongly with egg patent S. mansoni infection with a positive ameloriation response after PZQ treatment indicative of short term reversion of morbidity. Both tests were appropriate for use in the field with excellent operational performance and reliability. Due to its lower-cost which makes its scale-up of use affordable, FOB could be immediately adopted as a monitoring tool for PC campaigns for efficacy evaluation before and after treatment

Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis

Recent evidence indicates that single multiple sclerosis (MS) susceptibility genes involved in interferon (IFN) signaling display altered transcript levels in peripheral blood of untreated MS subjects, suggesting that responsiveness to endogenous IFN is dysregulated during neuroinflammation. To prove this hypothesis we exploited the systematic collection of IFN regulated genes (IRG) provided by the Interferome database and mapped Interferome changes in experimental and human MS. Indeed, central nervous system tissue and encephalitogenic CD4 T cells during experimental autoimmune encephalomyelitis were characterized by massive changes in Interferome transcription. Further, the analysis of almost 500 human blood transcriptomes showed that (i) several IRG changed expression at distinct MS stages with a core of 21 transcripts concordantly dysregulated in all MS forms compared with healthy subjects; (ii) 100 differentially expressed IRG were validated in independent case-control cohorts; and (iii) 53 out of 100 dysregulated IRG were targeted by IFN-beta treatment in vivo. Finally, ex vivo and in vitro experiments established that IFN-beta administration modulated expression of two IRG, ARRB1 and CHP1, in immune cells. Our study confirms the impairment of Interferome in experimental and human MS, and describes IRG signatures at distinct disease stages which can represent novel therapeutic targets in MS